
Lexicon Pharmaceuticals Investor Relations Material
Latest events

Q2 2025
Lexicon Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Lexicon Pharmaceuticals Inc
Access all reports
Lexicon Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of diseases with significant unmet medical needs. The company leverages its expertise in gene science to discover and develop small-molecule drugs aimed at addressing serious conditions such as heart disease, diabetes, and cancer. Lexicon's drug development approach involves targeting specific molecular pathways to create novel therapies that can alter the course of these diseases and improve patient outcomes. The company is headquartered in The Woodlands, Texas, and its shares are listed on the NASDAQ.
Key slides for Lexicon Pharmaceuticals Inc


Q2 2025
Lexicon Pharmaceuticals Inc


Corporate Presentation
Lexicon Pharmaceuticals Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
LXRX
Country
🇺🇸 United States